Spero Therapeutics (SPRO) Net Equity Issued and Repurchased (2016 - 2026)
Spero Therapeutics (SPRO) recorded Net Equity Issued and Repurchased of $1,000 in Q4 2023, compared with -$9.91 million a year earlier and down 99.5% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends
For FY2023, Spero Therapeutics reported Net Equity Issued and Repurchased of $221,000, down 47.4% from FY2022.
- Annual Net Equity Issued and Repurchased has declined for four straight years, with a five-year compound annual growth rate of -8.0% (FY2018 to FY2023).
- Across earlier years, Net Equity Issued and Repurchased came in at $420,000 in FY2022 (-71.0%), $1.45 million in FY2021 (-89.0%), $13.17 million in FY2020 (-16.6%) and $15.79 million in FY2019.
- Quarterly Net Equity Issued and Repurchased has ranged from -$38.9 million in Q3 2021 to $40 million in Q2 2021 over the past five years.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 689.1% in Q1 2021, against a decline of 99.9% in Q3 2019 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Spero Therapeutics | 58.73 Mn | -137.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 8,751.27 Bn |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 220,000.00 |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | 6.13 Mn |
| Jun 30, 2022 | 808,000.00 |
| Mar 31, 2022 | 3.81 Mn |
| Sep 30, 2021 | 27.54 Mn |
| Mar 31, 2021 | 4.35 Mn |
| Dec 31, 2020 | 11.10 Mn |
| Sep 30, 2020 | 35.56 Mn |
| Jun 30, 2020 | 7.54 Mn |
| Mar 31, 2020 | 21.12 Mn |
| Dec 31, 2019 | 5.60 Mn |
| Sep 30, 2019 | 89,000.00 |
| Jun 30, 2019 | 9.03 Mn |
| Mar 31, 2019 | 1.58 Mn |
API Access
Spero Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();